Journal: Antibiotics
Article Title: Development of New Antimicrobial Peptides by Directional Selection
doi: 10.3390/antibiotics14111120
Figure Lengend Snippet: Activity of synthetic peptides melittin ( A ), cecropin ( B ), and Hm-AMP2 ( C ) in relation to introduced mutations. In the alignment on the left, shades of blue indicate amino acid sequence similarities. On the right, antimicrobial activity against E. coli and B. subtilis , cytotoxicity toward Expi293F cells, and the calculated therapeutic index based on peptide activities are shown. MEL—melittin, CECR—cecropin, AMP2—Hm-AMP2 peptide. AMP’s cytotoxicity was measured as the IC 90 , the concentration that inhibits 90% of cell growth. NA (not applicable) indicates that peptide showed no activity within tested concentration range. Minimal inhibitory concentration (MIC) and IC 90 are given in µM. The therapeutic index (TI) was defined as the lowest IC 90 divided by the highest MIC.
Article Snippet: The strain used for recombinant plasmid construction was E. coli TOP10 (F − mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697 galE15 galK16 rpsL(Str^R) endA1 λ − ) (Invitrogen, Carlsbad, CA, USA).
Techniques: Activity Assay, Sequencing, Concentration Assay